We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$207B
AUM Growth
+$20.6B
Cap. Flow
+$7.99B
Cap. Flow %
3.86%
Top 10 Hldgs %
26.62%
Holding
9,816
New
1,347
Increased
3,278
Reduced
3,435
Closed
1,488

Sector Composition

Rank Sector Weight
1 Consumer Staples 2.31%
2 Technology 1.26%
3 Financials 1.12%
4 Healthcare 1.04%
5 Consumer Discretionary 0.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INFI
8026
CALL
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$69K ﹤0.01%
44,400
-10,800
-20% -$16.6K
SPPI
8027
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$69K ﹤0.01%
+14,800
New +$87.7K
VSLR
8028
CALL
DELISTED
VIVINT SOLAR, INC.
VSLR
$69K ﹤0.01%
+21,700
New +$67.1K
VISN
8029
CALL
DELISTED
VisionChina Media, Inc.
VISN
$69K ﹤0.01%
+11,100
New +$69.6K
ARAY icon
8030
Accuray
ARAY
$31.7M
$68K ﹤0.01%
+10,609
New +$57.9K
LGCY
8031
PUT
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$68K ﹤0.01%
50,000
+14,200
+40% +$22.9K
PGH
8032
DELISTED
Pengrowth Energy Corporation
PGH
$68K ﹤0.01%
+42,662
New +$66.9K
AWRE icon
8033
Aware
AWRE
$26.6M
$67K ﹤0.01%
+12,682
New +$63.7K
OREX
8034
DELISTED
Orexigen Therapeutics, Inc.
OREX
$67K ﹤0.01%
20,143
+8,680
+76% +$32.8K
NSLR
8035
Neostellar Capital Corp
NSLR
$271M
$66K ﹤0.01%
16,550
-4,564
-22% -$19.9K
IVAC
8036
DELISTED
Intevac Inc
IVAC
$66K ﹤0.01%
+11,170
New +$66.4K
EVEP
8037
PUT
DELISTED
EV Energy Partners, L.P.
EVEP
$66K ﹤0.01%
27,300
-16,200
-37% -$38.8K
ABEO icon
8038
CALL
Abeona Therapeutics
ABEO
$345M
$65K ﹤0.01%
+436
New +$42.6K
APT icon
8039
Alpha Pro Tech
APT
$53.9M
$64K ﹤0.01%
+17,647
New +$51.1K
CARM
8040
PUT
DELISTED
Carisma Therapeutics
CARM
$64K ﹤0.01%
+1,150
New +$85.6K
OCSL icon
8041
PUT
Oaktree Specialty Lending
OCSL
$1.15B
$64K ﹤0.01%
3,667
-7,333
-67% -$126K
PLUR icon
8042
PUT
Pluri
PLUR
$16.3M
$64K ﹤0.01%
503
-70
-12% -$8.82K
ONDK
8043
PUT
DELISTED
On Deck Capital, Inc.
ONDK
$64K ﹤0.01%
11,300
-3,800
-25% -$21.7K
RXDX
8044
DELISTED
Ignyta, Inc.
RXDX
$64K ﹤0.01%
+10,097
New +$58.7K
ACW
8045
PUT
DELISTED
Accuride Corp
ACW
$64K ﹤0.01%
+25,000
New +$44.6K
NADL
8046
CALL
DELISTED
North Atlantic Drilling Ltd
NADL
$63K ﹤0.01%
20,800
-6,300
-23% -$26.9K
HLTH
8047
PUT
DELISTED
Nobilis Health Corp.
HLTH
$62K ﹤0.01%
18,400
+4,700
+34% +$14.1K
MOBL
8048
PUT
DELISTED
MobileIron, Inc.
MOBL
$62K ﹤0.01%
22,600
-400
-2% -$1.24K
CLIR icon
8049
PUT
ClearSign Technologies
CLIR
$32.2M
$61K ﹤0.01%
+1,020
New +$50.7K
PERI icon
8050
Perion Network
PERI
$374M
$61K ﹤0.01%
17,021
+12,649
+289% +$48.1K

Similar funds

Jeff Yass's Q3 2016 Portfolio in Review

As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.

By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Apple, an estimated $762M trimmed.

  • Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
  • Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
  • Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
  • Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
  • Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
  • Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
  • Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.

Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.